Genomed (WAR:GEN) Beneish M-Score : -2.73 (As of Dec. 15, 2024)

View and export this data going back to 2011. Start your Free Trial

What is Genomed Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.73 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Genomed's Beneish M-Score or its related term are showing as below:

WAR:GEN' s Beneish M-Score Range Over the Past 10 Years
Min: -5.71 Med: -2.18 Max: -0.4
Current: -2.73

During the past 13 years, the highest Beneish M-Score of Genomed was -0.40. The lowest was -5.71. And the median was -2.18.

Genomed Beneish M-Score Historical Data

The historical data trend for Genomed's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomed Beneish M-Score Chart

Genomed Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Beneish M-Score

Get a 7-Day Free Trial

-2.26

-3.59

-2.24

-1.27

-2.65

Genomed Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Beneish M-Score	Get a 7-Day Free Trial															-2.26	-2.65	-2.73	-2.34	-2.73

Competitive Comparison of Genomed's Beneish M-Score

For the Diagnostics & Research subindustry, Genomed's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genomed's Beneish M-Score Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genomed's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Genomed's Beneish M-Score falls into.

Genomed Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Genomed for today is based on a combination of the following eight different indices:

-4.84

0.92 * DSRI

0.528 * GMI

0.404 * AQI

0.892 * SGI

0.115 * DEPI

-4.84

0.92 * 1.0953

0.528 * 0.9519

0.404 * 0.8901

0.892 * 1.0803

0.115 * 1.5387

0.172 * SGAI

4.679 * TATA

0.327 * LVGI

0.172 * 1

4.679 * -0.086876

0.327 * 0.9769

-2.73

This Year (Sep24) TTM:

Last Year (Sep23) TTM:

Total Receivables was zł1.94 Mil.
Revenue was 5.619 + 5.203 + 5.035 + 7.208 = zł23.07 Mil.
Gross Profit was 3.599 + 3.044 + 2.784 + 5.098 = zł14.53 Mil.
Total Current Assets was zł7.05 Mil.
Total Assets was zł10.84 Mil.
Property, Plant and Equipment(Net PPE) was zł2.32 Mil.
Depreciation, Depletion and Amortization(DDA) was zł0.68 Mil.
Selling, General, & Admin. Expense(SGA) was zł0.00 Mil.
Total Current Liabilities was zł0.90 Mil.
Long-Term Debt & Capital Lease Obligation was zł0.00 Mil.
Net Income was 0.355 + -0.175 + -0.615 + 1.313 = zł0.88 Mil.
Non Operating Income was 0 + 0 + 0 + 0 = zł0.00 Mil.
Cash Flow from Operations was 0.474 + 0.08 + -0.925 + 2.191 = zł1.82 Mil.

Total Receivables was zł1.64 Mil.
Revenue was 4.692 + 4.797 + 5.785 + 6.076 = zł21.35 Mil.
Gross Profit was 2.967 + 2.917 + 3.125 + 3.789 = zł12.80 Mil.
Total Current Assets was zł7.01 Mil.
Total Assets was zł9.75 Mil.
Property, Plant and Equipment(Net PPE) was zł1.25 Mil.
Depreciation, Depletion and Amortization(DDA) was zł0.67 Mil.
Selling, General, & Admin. Expense(SGA) was zł0.00 Mil.
Total Current Liabilities was zł0.83 Mil.
Long-Term Debt & Capital Lease Obligation was zł0.00 Mil.

1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI	=	(Receivables_t / Revenue_t)	/	(Receivables_t-1 / Revenue_t-1)
	=	(1.937 / 23.065)	/	(1.637 / 21.35)
	=	0.08398	/	0.076674
	=	1.0953

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI	=	GrossMargin_t-1	/	GrossMargin_t
	=	(GrossProfit_t-1 / Revenue_t-1)	/	(GrossProfit_t / Revenue_t)
	=	(12.798 / 21.35)	/	(14.525 / 23.065)
	=	0.599438	/	0.629742
	=	0.9519

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI	=	(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t)	/	(1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
	=	(1 - (7.046 + 2.319) / 10.843)	/	(1 - (7.01 + 1.246) / 9.749)
	=	0.136309	/	0.153144
	=	0.8901

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI	=	Sales_t	/	Sales_t-1
	=	Revenue_t	/	Revenue_t-1
	=	23.065	/	21.35
	=	1.0803

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI	=	(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1))	/	(Depreciation_t / (Depreciaton_t + PPE_t))
	=	(0.67 / (0.67 + 1.246))	/	(0.682 / (0.682 + 2.319))
	=	0.349687	/	0.227258
	=	1.5387

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI	=	(SGA_t / Sales_t)	/	(SGA_t-1 /Sales_t-1)
	=	(0 / 23.065)	/	(0 / 21.35)
	=	0	/	0
	=	1

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI	=	((LTD_t + CurrentLiabilities_t) / TotalAssets_t)	/	((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
	=	((0 + 0.904) / 10.843)	/	((0 + 0.832) / 9.749)
	=	0.083372	/	0.085342
	=	0.9769

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA	=	(IncomefromContinuingOperations_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(NetIncome_t - NonOperatingIncome_t	-	CashFlowsfromOperations_t)	/	TotalAssets_t
	=	(0.878 - 0	-	1.82)	/	10.843
	=	-0.086876

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Genomed has a M-score of -2.73 suggests that the company is unlikely to be a manipulator.

Genomed Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Genomed's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.

Genomed Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genomed SA (WAR:GEN) » Definitions » Beneish M-Score

Comparable Companies

Traded in Other Exchanges

N/A

Address

Ulica Ponczowa 12, Warszawa, POL, 02-971

Website

http://www.genomed.pl

Genomed SA assembles outstanding molecular biologists and genetic diagnosticians. The company provides diagnostic service that comprises DNA analysis and congenital diseases diagnostics based on DNA sequencing. It offers Diagnostic service and Service for scientific purposes.